The Global electrochemical biosensors market, is projected to grow at a CAGR of 9.7% and is expected to reach USD 23707.2 million by 2022. Globally North America accounted for the largest market share in 2016.
Over the past few years nanotechnology has becoming increasingly essential in the field of biosensors. The performance and sensitivity of biosensors is incredibly enhanced with the combination of nanomaterials into their construction. The biosensors works on various technologies which include electrochemical biosensors, optical biosensors, thermal biosensors and piezoelectric biosensors. This report by MRFR majorly focuses on the electrochemical biosensors which holds the largest market share among all others biosensor technologies. The Electrochemical biosensors plays a major role in the field of healthcare which include applications such as diagnosis, patient monitoring and many others. The end user such as point of care testing, diagnostics centers, research laboratories and various others influence the growth of the market.
The global market of electrochemical biosensors is growing rapidly at the CAGR of around 9.7% for the forecasted period. The growth of the market is likely to driven by increasing diabetic population, rising prevalence of chronic and lifestyle induced disease, increasing demand for POCT, increasing application of biosensors in various industries. However, factors such as strict regulatory requirements, reimbursement policies issues in healthcare systems is further hampering the market.
Global Electrochemical Biosensors Market Share, By End User, 2016 (% Share)
Market Synopsis of Electrochemical biosensors Market:
Global Electrochemical biosensors market has been segmented on the basis of applications which comprises of diagnosis, monitoring and others. Furthermore on the basis of end users the market is segmented into point of care testing, diagnostics center, research laboratories and others.
Regional Analysis of Electrochemical biosensors Market:
North America is the largest market of global electrochemical biosensors market which is expected to grow at the CAGR of 9.4%. In North America, electrochemical biosensor market is driven due to increasing health awareness, rising chronic and lifestyle diseases, technological developments in healthcare applications, and appropriate insurance coverage.
Usage of biosensor technology in North America is higher as compared to other regions of the world due to technological advancements and broader application areas in different industries. Since, the healthcare expenditure is high in North America, biosensor devices are used extensively for accurate, reliable and quick results for early detection and prevention of diseases.
Europe is the second largest market for electrochemical biosensors which is expected to grow at a CAGR of 9.8%.
Asia Pacific region is expected to be fastest growing region of this market. The electrochemical biosensors market in Asia-Pacific region is growing due to increasing awareness of clinical outcomes, large population base, rise in geriatric population, increase in diabetic population and technological advancement in medical devices and equipment. The awareness of various diseases and requirement of high quality care is increasing day by day. For instance, according to a study conducted by National Centre for Biotechnology Information (NCBI) in 2012, approximately 60% of Asian population was suffering from diabetes and the prevalence of diabetes is increasing. In addition, Asia-Pacific has become one of the attractive markets for medical device companies due to low regulatory requirements and low cost manufacturing of devices.
Key Players for Electrochemical biosensors Market:
Some of the key players in this market are: F. Hoffmann-La Roche AG, Medtronics, Bayer AG, Abbott Laboratories, I-SENS, Inc, Siemens Healthcare GmbH and others.
The report of Electrochemical biosensors Market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives an extensive study about different markets segments and regions.
Table of Contents
1 Report Prologue
1.1.1 Global Electrochemical Biosensors Market, By Application
1.1.2 Global Electrochemical Biosensors Market, By End User
1.1.3 Global Electrochemical Biosensors Market, By Region
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.2.1 Increasing diabetic population
4.2.2 Rising prevalence of chronic and lifestyle induced disease
4.2.3 Increasing demand for POCT
4.2.4 Increasing application of biosensors in various industries
4.3.1 Strict regulatory requirements
4.3.2 Reimbursement policies issues in healthcare systems
4.4.1 Opportunity from increasing demand of personalized medicine
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Buyers
5.1.2 Bargaining Power of Suppliers
5.1.3 Threat of New Entrants
5.1.4 Intensity of Rivalry
5.1.5 Threat of Substitutes
6 Global Electrochemical Biosensors Market, By Application
6.4 Other Applications
7 Global Electrochemical Biosensors Market, By End User
7.2 Point of Care Testing
7.3 Diagnostics Center
7.4 Research Laboratories
8 Global Electrochemical Biosensors Market, By Region
8.2 North America
8.3.6 Rest of Europe
8.4.4 Republic of Korea
8.4.5 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
9 Competitive Landscape
10 Company Profile
10.1 F. Hoffmann-La Roche AG
10.1.1 Company Overview
10.1.2 Product/Business Segment Overview
10.1.4 Key Developments
10.2.1 Company Overview
10.2.2 Product/Business Segment Overview
10.2.3 Financial Overview
10.2.4 Key Development
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Product/Business Segment Overview
10.3.3 Financial Updates
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Product/Business Segment Overview
10.4.3 Financial Updates
10.5 I-SENS, Inc.
10.5.1 Company Overview
10.5.2 Product/Business Segment Overview
10.5.3 Financial Updates
10.5.4 Key Development
10.6 Siemens Healthcare GmbH
10.6.1 Company Overview
10.6.2 Product/Business Segment Overview
10.6.3 Financial Updates
10.6.4 Key Development